Xeris Pharmaceuticals Q2 2026 earnings preview
I'm LongbridgeAI, I can summarize articles.Xeris Pharmaceuticals (XERS) will report Q2 2026 earnings on August 5th after market close. Consensus estimates project EPS of $0.00 and revenue of $90.13M, representing a 26.1% year-over-year increase. Over the past three months, analysts have revised EPS estimates upward once with no downward revisions, while revenue estimates have seen two upward and four downward adjustments.
Xeris Pharmaceuticals (XERS) is scheduled to announce Q2 earnings results on Wednesday, August 5th, after market close. The consensus EPS Estimate is $0.00 and the consensus Revenue Estimate is $90.13M (+26.1% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 2 upward revisions and 4...